To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"Now that we know that we can target the basic molecular defects in Alzheimer's disease, we can hope for treatments far better—and more specific—than anything we have today." -Dr. Gerald Weissmann

A new ray of hope has broken through the clouded outcomes associated with Alzheimer's disease. A new research report published in January 2013 print issue of the FASEB Journal (Federation of the American Societies for Experimental Biology) by scientists from the National Institutes of Health shows that when a molecule called TFP5 is injected into mice with disease that is the equivalent of human Alzheimer's, symptoms are reversed and memory is restored—without obvious toxic side effects.

"We hope that clinical trial studies in AD patients should yield an extended and a better quality of life as observed in mice upon TFP5 treatment," said Harish C. Pant, Ph.D., a senior researcher involved in the work from the Laboratory of Neurochemistry at the National Institute of Neurological Disorders at Stroke at the National Institutes of Health in Bethesda, MD. "Therefore, we suggest that TFP5 should be an effective therapeutic compound." (Photo by: Cécile Graat)

To make this discovery, Pant and colleagues used mice with a disease considered the equivalent of Alzheimer's. One set of these mice were injected with the small molecule TFP5, while the other was injected with saline as placebo. The mice, after a series of intraperitoneal injections of TFP5, displayed a substantial reduction in the various disease symptoms along with restoration of memory loss. In addition, the mice receiving TFP5 injections experienced no weight loss, neurological stress (anxiety) or signs of toxicity. The disease in the placebo mice, however, progressed normally as expected. TFP5 was derived from the regulator of a key brain enzyme, called Cdk5. The over activation of Cdk5 is implicated in the formation of plaques and tangles, the major hallmark of Alzheimer's disease.

"The next step is to find out if this molecule can have the same effects in people, and if not, to find out which molecule will," said Gerald Weissmann, M.D., Editor-in-Chief of the FASEB Journal. "Now that we know that we can target the basic molecular defects in Alzheimer's disease, we can hope for treatments far better—and more specific—than anything we have today."

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Trump Celebrates 'Wonderful' Children With Down Syndrome: 'You Are Amazing'

ICYMI: Governor Abbott Signs Law Banning Sharia Compounds in Texas

Rubio Deports Suspected Muslim Brotherhood Leader

FBI's Big Sweep - 'We Rescued Thousands of Children': Five Days, Numerous Cities and One Big Bite Out of Crime

Mystery Billionaire Who Donated $130M to Pay Our Troops During Shutdown Has Been Identified

Largest Federal Workers Union Calls for an End to the Shutdown, Putting Pressure on Democrats

Egypt Joins Search for 13 Hostage Bodies, Including 2 Americans; Trump Issues Ultimatum

Prayer Alert: Hurricane Melissa Nears Jamaica as Category 5

Peace President Trump Signs Thailand-Cambodia Peace Deal He Helped Broker during Stop in Malaysia

'This Is a Historic First': Conservative Influencer Benny Johnson Says Trump Changed Charlie Kirk's Award to Include a Cross

White House Ballroom Construction: Presidents Have Made Changes for Decades

Judge Rules against Trump Admin Effort to Purge 'Woke' Books from Military Schools

Wow! Deadly Illegal Alien Truck Driver Failed CDL Test 10 Times

Trump: Tech Leaders, Mayor Persuaded Me to Hold Off Federal Force in San Francisco

FBI Director Kash Patel: We're 'On the Verge' of Exposing Antifa's Funding Network

Inflation Eases in September, Below Analysts' Expectations; But Shutdown Needs to End

Cultural Transformation Is Happening in America among the Youth

Stunning Archaeological Discovery That Offered Powerful Biblical Proof: Inside the Dead Sea Scrolls

Biblical Tax Notice: 1st-ever Assyrian Inscription Found Near Jerusalem's Temple Mount

'A Genocide Is Happening': 35 Christian Leaders Urge Trump to Declare Nigeria a CPC

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor